Transfusion and COVID-19 (TRANSCOV-19)

University Hospital, Strasbourg, France

Status: Unknown

Conditions: COVID-19

Study type: Observational

Funder types: Other

Identifiers

NCT05075915

7958

Details and patient eligibility

About

Alsace was particularly and early on affected by SARS-CoV-2 and quickly implemented a reduction in scheduled admissions and non-urgent surgical interventions, making it possible to reduce requests for labile blood products linked to non-urgent surgical procedures. as has been reported in the literature; the population containment measures also led to a major reduction in traffic - and consequently accidents on the public roads. At the same time, other demands for blood products related to activities such as onco-hematology were little affected. Finally, the blood banks have adapted their collection procedure.

To answer these questions, we propose to conduct a retrospective study over two parallel periods of 2019 and 2020 of the consumption of blood products on the one hand and the availability of stocks on the other hand.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

• Adults patient (≥18 years old)
• Patients admitted to Strasbourg University Hospitals for suspicion of Covid-19, between February 24 and May 31 of 2019 and 2020
• Labile blood products consumed between February 24 and May 31 of 2019 and 2020
• Subjects not having his opposition, after information, to the reuse of his data for the purposes of this research.

Non-inclusion criteria:

• Patients who expressed opposition to participating in the study
• Patients under legal protection
• Patients under guardianship or curatorship